Results 191 to 200 of about 1,971,842 (244)

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned! [PDF]

Clin Case Rep
Mathur M, Paudel S, Bhattarai N, Karki S, Regmi S.   +4 more
europepmc   +1 more source

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]

Cureus
Khan JA, Shahab S.
europepmc   +1 more source

Bullous Non-Pigmenting Fixed Drug Eruption. [PDF]

Dtsch Arztebl Int
Qian MY, Tan C.
europepmc   +1 more source

Pediatric Lichen Planus Pemphigoides in a Child With Sickle Cell Disease: Cyclosporine Induction and Dupilumab Maintenance

Pediatric Dermatology, EarlyView.
ABSTRACT Lichen planus pemphigoides (LPP) is a rare autoimmune subepidermal blistering disorder that combines lichenoid lesions of lichen planus with immunopathologic features of pemphigoid disease. We report an 8‐year‐old boy with homozygous sickle cell disease and severe atopic dermatitis who developed diffuse pruritic violaceous papules followed by ...
Yumeng T. Engelking, Laura Correa Ferrer, Jazmin Newton, Kristen G. Berrebi   +3 more
wiley   +1 more source

Fixed Drug Eruption Following Concurrent Ciprofloxacin and Metronidazole Therapy: A Dermoscopy-Assisted Diagnosis. [PDF]

Cureus
Tuesta Buchelli P, Terrones Huamán DD, Reynel KJ, Barrios Aedo JJ, Collahua Cabana R.   +4 more
europepmc   +1 more source

Pediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Hospitalizations in the United States

Pediatric Dermatology, EarlyView.
ABSTRACT Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare life‐threatening mucocutaneous reactions that remain poorly characterized in pediatric populations. Using the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID), the prevalence of SJS/TEN hospitalizations declined from 0.02% in 2016 to 0.009%
Shazli Razi, Priya Agarwal, Gaurav N. Pathak, Christian Kaunzinger, Aaron Morgan, Babar K. Rao   +5 more
wiley   +1 more source

Clinicopathological Characteristics of Lichenoid Drug Eruption: A 17-Year Retrospective Study. [PDF]

Clin Cosmet Investig Dermatol
Promsena P, Iamsumang W, Rutnin S.
europepmc   +1 more source

Interim Update on Reactive Infectious Mucocutaneous Eruption (RIME)

Pediatric Dermatology, EarlyView.
ABSTRACT Reactive infectious mucocutaneous eruption (RIME), a term describing blistering skin and mucosal lesions, is a term coined by a group of Pediatric Dermatology Research Alliance (PeDRA) researchers and first published in 2021. Since that time, the literature has grown with reports of diverse infectious triggers, management strategies, and ...
Michele Ramien, Yvonne E. Chiu, Sarah D. Cipriano, Sadaf Hussain, A. Yasmine Kirkorian, Minnelly Luu, Erin F. Mathes, Vikash S. Oza, Martin Theiler, James R. Treat, Patrick M. Meyer Sauteur, Irene Lara‐Corrales   +11 more
wiley   +1 more source

Candesartan-Associated Lichenoid Drug Eruption. [PDF]

Cureus
Iijima K, Mima Y.
europepmc   +1 more source

Nimesulide-Associated Generalized Bullous Fixed Drug Eruption: A Rare Pharmacovigilance Case Report. [PDF]

Cureus
Marshal M, Aggarwal S, Joseph G, Bhatti N, Badyal DK.   +4 more
europepmc   +1 more source